摘要:
The present invention discloses a composition comprising readily dissociable molecular aggregates formed by combining an insulin, insulin analogue, derivative or metabolite having isoelectric point between 5.8 to 8.5 in combination with one or more an insulin, insulin analogue, derivative or metabolite having isoelectric point between 4.0 to 5.7.
摘要:
The invention provides an a pharmaceutical composition for transdermal or transmucosal administration comprising insulin, insulin analogues or derivatives, an effective amount of herbal oil and one or more surfactant or polymeric ingredient optionally along with one or more pharmaceutically acceptable excipients for treating diabetic disorders.